SuperworthKorsana Biosciences shares outstanding KRSA
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 607.3K
- On a year earlier
- +38.4%
- more shares
Korsana Biosciences had 607.3K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 38.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 543.4K | +50% |
| FY2024 | 363.1K | +4% |
| FY2023 | 350.6K | +13% |
| FY2022 | 310.4K | +0% |
| FY2021 | 309.6K | +27% |
| FY2020 | 242.8K | +24% |
| FY2019 | 195.6K | +0% |
| FY2018 | 195.6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 607.3K | +38% | |
| Q1 FY26 | 600.7K | +65% | |
| Q4 FY25 | 543.4K | +50% | |
| Q3 FY25 | 460.7K | +28% | |
| Q2 FY25 | 438.7K | +22% | |
| Q1 FY25 | 365.1K | +2% | |
| Q4 FY24 | 363.1K | +4% | |
| Q3 FY24 | 360.9K | −9% | |
| Q2 FY24 | 358.6K | +10% | |
| Q1 FY24 | 356.3K | +15% | |
| Q4 FY23 | 350.6K | +13% | |
| Q3 FY23 | 398K | +28% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Korsana Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.